Scott T. Garrett, Director at HCW Biologics Inc. (HCWB), bought 5,385 shares at $26.00 ($140K) on 2025-05-08, disclosed to the SEC on 2025-05-09.
Open-market purchase of $140k HCWB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| HCWB | BUY | 2025-05-20 | $200K | — | Filing → |
| HOLX | SELL | 2024-03-15 | $2.5M | — | Filing → |
| HOLX | SELL | 2023-12-13 | $1.4M | — | Filing → |